233 related articles for article (PubMed ID: 32022432)
21. Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection.
Brett MM; Ghoneim AT; Littlewood JM
Arch Dis Child; 1987 Apr; 62(4):357-61. PubMed ID: 3109335
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.
Pedersen SS; Espersen F; Høiby N; Jensen T
J Clin Microbiol; 1990 Apr; 28(4):747-55. PubMed ID: 2110181
[TBL] [Abstract][Full Text] [Related]
23. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
[TBL] [Abstract][Full Text] [Related]
24. Dissociation of systemic and mucosal autoimmunity in cystic fibrosis.
Theprungsirikul J; Skopelja-Gardner S; Meagher RE; Clancy JP; Zemanick ET; Ashare A; Rigby WFC
J Cyst Fibros; 2020 Mar; 19(2):196-202. PubMed ID: 31262645
[TBL] [Abstract][Full Text] [Related]
25. A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.
Yamashita M; Hida Y; Sugimoto H; Takahashi N; Kimura H; Nakatomi Y; Yoshida H; Ishizaki T
J Microbiol Methods; 2010 Sep; 82(3):198-204. PubMed ID: 20538018
[TBL] [Abstract][Full Text] [Related]
26. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.
Schuster A; Haarmann A; Wahn V
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S59-60. PubMed ID: 7537567
[TBL] [Abstract][Full Text] [Related]
27. Anti-protease levels in cystic fibrosis are associated with lung function, recovery from pulmonary exacerbations and may be gender-related.
Essilfie AT; Houston N; Maniam P; Hartel G; Okano S; Reid DW
Respirology; 2023 Jun; 28(6):533-542. PubMed ID: 36642534
[TBL] [Abstract][Full Text] [Related]
28. Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum.
Hann S; Holsclaw DS
Infect Immun; 1976 Jul; 14(1):114-7. PubMed ID: 820637
[TBL] [Abstract][Full Text] [Related]
29. Bacterial reservoirs in cystic fibrosis.
Taylor CJ; McGaw J; Howden R; Duerden BI; Baxter PS
Arch Dis Child; 1990 Feb; 65(2):175-7. PubMed ID: 2317061
[TBL] [Abstract][Full Text] [Related]
30. Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis.
Henriksson G; Westrin KM; Karpati F; Wikström AC; Stierna P; Hjelte L
Chest; 2002 Jan; 121(1):40-7. PubMed ID: 11796430
[TBL] [Abstract][Full Text] [Related]
31. The burden of sinus disease in cystic fibrosis lung transplant recipients.
Morlacchi LC; Greer M; Tudorache I; Blasi F; Welte T; Haverich A; Mainz JG; Gottlieb J
Transpl Infect Dis; 2018 Oct; 20(5):e12924. PubMed ID: 29797646
[TBL] [Abstract][Full Text] [Related]
32. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
Fick RB; Naegel GP; Squier SU; Wood RE; Gee JB; Reynolds HY
J Clin Invest; 1984 Jul; 74(1):236-48. PubMed ID: 6429195
[TBL] [Abstract][Full Text] [Related]
33. Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis.
Taylor RF; Morgan DW; Nicholson PS; Mackay IS; Hodson ME; Pitt TL
Thorax; 1992 Jun; 47(6):426-8. PubMed ID: 1496501
[TBL] [Abstract][Full Text] [Related]
34. Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA).
Mauch RM; Rossi CL; Ribeiro JD; Ribeiro AF; Nolasco da Silva MT; Levy CE
Diagn Pathol; 2014 Aug; 9():158. PubMed ID: 25146522
[TBL] [Abstract][Full Text] [Related]
35. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.
Malhotra S; Hayes D; Wozniak DJ
J Cyst Fibros; 2019 Nov; 18(6):796-803. PubMed ID: 31036488
[TBL] [Abstract][Full Text] [Related]
36. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
[TBL] [Abstract][Full Text] [Related]
37. Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Fomsgaard A; Dinesen B; Shand GH; Pressler T; Høiby N
J Clin Microbiol; 1989 Jun; 27(6):1222-9. PubMed ID: 2502558
[TBL] [Abstract][Full Text] [Related]
38. Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis.
Pedersen SS; Møller H; Espersen F; Sørensen CH; Jensen T; Høiby N
APMIS; 1992 Apr; 100(4):326-34. PubMed ID: 1581041
[TBL] [Abstract][Full Text] [Related]
39. Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization.
Aanaes K; Johansen HK; Poulsen SS; Pressler T; Buchwald C; Høiby N
J Cyst Fibros; 2013 Jan; 12(1):81-7. PubMed ID: 22819141
[TBL] [Abstract][Full Text] [Related]
40. Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis.
Gaweł J; Pogorzelski A; Działek-Smętek E; Sochań B; Ligarska R; Lącka M; Mazurek H
Pneumonol Alergol Pol; 2014; 82(4):336-41. PubMed ID: 24964236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
